Back
ESC Premium Access

Geographic region, stroke risk and renal function strongly affect treatment choice for stroke prevention in patients with non-valvular AF: results from the GLORIA-AF registry program

Session: Atrial fibrillation - Anticoagulation
Topic: Stroke Prevention
Speaker: Doctor L. Riou Franca (Ingelheim, DE)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Lionel Riou Franca

Ingelheim (Germany)
0 follower

6 more presentations in this session

NOACs versus warfarin in atrial fibrillation patients and risk of dementia: a nationwide propensity-weighted cohort study

Speaker: Mrs M. Soegaard (Aalborg, DK)

Access
Abstract
Slides
Like
Thumbnail

Resuming anticoagulation in patients with atrial fibrillation experiencing hemorrhage stroke or nontraumatic intracranial hemorrhage

Speaker: Assistant Professor V. Wu (Tao-Yuan, TW)

Access
Abstract
Slides
Like
Thumbnail

Identification of atrial fibrillation patients who are at high bleeding risk after undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI trial

Speaker: Doctor T. Nafee (Boston, US)

Access
Abstract
Slides
Like
Thumbnail

Thrombosis of left atrial appendage closure devices - What is the clinical impact?

Speaker: Doctor V. Lekesova (Prague, CZ)

Access
Abstract
Slides
Like
Thumbnail

Effect of anticoagulation on mortality by CHADSVASC score in patients with atrial fibrillation: comparison to patients without atrial fibrillation

Speaker: Doctor S. Harb (Cleveland, US)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Atrial fibrillation - Anticoagulation

Speakers: Doctor L. Riou Franca, Mrs M. Soegaard, Assistant Professor V. Wu, Doctor T. Nafee, Doctor V. Lekesova...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources